Thor Medical ASA will release its first half results on Friday 29 August 2025 at 07:00 am (CEST).

A presentation of the results followed by a Q&A session will be held on the same day at 08:00 am at Sjølyst Møtesenter, Drammensveien 167, and through a live webcast. The presentation and the Q&A session can be followed through a live webcast from our website www.thormedical.com or Thor Medical 1H 2025.

‍

Contacts:

Brede Ellingsæter, CFO & COO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com

About Thor Medical:

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.com

‍

Contacts

Attachments